When did the partnership between REJECT and Rohto Pharmaceutical start?

The partnership was established in 2023, and the renewal for fiscal year 2026 has been announced.

What is the main purpose of this contract renewal?

To jointly promote communication and initiatives that are naturally accepted by the gaming community.

What kind of esports team is REJECT?

Founded in 2018, it boasts the largest number of title divisions and world tournament appearances in Japan, with cumulative prize money exceeding 750 million yen, ranking first domestically.

AI News NQ Analysis

Esports Team 'REJECT' Renews Partnership Agreement with Rohto Pharmaceutical

NQ Score 0/100

N1 Content Completeness 9

AI Summary (NQ-processed)

REJECT Inc., operator of the esports team 'REJECT', has renewed its partnership agreement with Rohto Pharmaceutical Co., Ltd., continuing their collaboration through fiscal year 2026. The two companies have been jointly developing initiatives for the gaming community since 2023.

AI Analysis

Frequently Asked Questions

Q: When did the partnership between REJECT and Rohto Pharmaceutical start?: A: The partnership was established in 2023, and the renewal for fiscal year 2026 has been announced.
Q: What is the main purpose of this contract renewal?: A: To jointly promote communication and initiatives that are naturally accepted by the gaming community.
Q: What kind of esports team is REJECT?: A: Founded in 2018, it boasts the largest number of title divisions and world tournament appearances in Japan, with cumulative prize money exceeding 750 million yen, ranking first domestically.